ANIXA BIOSCIENCE (ANIX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in ANIX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$1.2M
Across holders
Last Price
$2.61
2026-10-19
Sector
Health Care
GICS
Quarterly fund activity2 increased1 reduced2 exited
Full exits: TWO SIGMA INVESTMENTS, LP, Point72 Asset Management, L.P.
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 328K | $919K | 78.0% | 0.0% | Added | +$134K | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 59K | $166K | 14.1% | 0.0% | Reduced | $-5K | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 32K | $89K | 7.6% | 0.0% | Added | +$30K | Q2 2026 |
| Ancora Advisors, LLC CIK 0001446114 | Hedge Fund | 1K | $4K | 0.3% | 0.0% | Unchanged | +$0 | Q2 2026 |
Recent insider activity
Form 4 purchases and sales · 24 Jul 2026 – 21 Oct 20261 buyers · $159K0 sellers · $02 transactions
| Insider ⇅ | Trades ⇅ | Bought ⇅ | Sold ⇅ | Largest ⇅ | Latest ▼ | |
|---|---|---|---|---|---|---|
| Titterton Lewis H jr Director | 2 2 buy · 0 sell | $159K | — | $132K | 23 Sept 2026SEC ↗ |
Distinct buyers and sellers may overlap. “Largest” is the largest reported transaction value in this window. Expand a row to see up to five recent filings.